Search Tag: gadolinium-based contrast agents
Rsna18-ai-may-help-reduce-mri-gadolinium-dose
2018 27 Nov
In a study presented at the annual meeting of the Radiological Society of North America (RSNA) in Chicago, researchers using artificial intelligence have developed a deep learning algorithm that may lead to the reduction of the gadolinium dose used in contrast material for MRI exams. “There is concrete evidence that gadolinium deposits in the brain...Read more
Study-gadolinium-deposition-in-brain-tissues-more-widespread
2017 27 Jun
Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. New research suggests however that gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents. The findings,...Read more